104 results
Page 4 of 6
8-K
EX-99.1
sacn1if0
25 Mar 21
Diffusion Pharmaceuticals Completes Enrollment and Dosing in TCOM Study
5:20pm
8-K
EX-99.1
32cqctee0kexntgz9dj
18 Mar 21
Regulation FD Disclosure
4:14pm
8-K
EX-99.1
eh18kscgece
17 Mar 21
Diffusion Pharmaceuticals Reports 2020 Financial Results and Provides Business Update
4:36pm
8-K
EX-99.1
wb8 2v10de
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
8-K
EX-99.2
3pfkth5wivsqrztlpa5
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
8-K
EX-99.3
9ob 03lu2jri6j2ghoav
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
8-K
EX-99.4
dhdgbcbljc3xbwu
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
424B5
4xs04a
17 Feb 21
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
v5r51p 5a6wyq
16 Feb 21
Diffusion Pharmaceuticals Completes Phase 1b Study of TSC in Hospitalized COVID-19 Patients
8:10am
8-K
EX-99.1
mpkoje0
12 Feb 21
Note Regarding Forward-looking Statements
8:19am
FWP
3s6cf5vyquygd
11 Feb 21
Free writing prospectus
9:56pm
FWP
p4wtx fae04pi
11 Feb 21
Free writing prospectus
5:29pm
424B5
8ejzt6pdy8taai03xa6x
11 Feb 21
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
vw8ay7czcj 99x36
12 Nov 20
Diffusion Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Updates
4:57pm
8-K
EX-10.1
eu97a0
20 Oct 20
Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer
5:30pm
424B2
8c8rk4s
2 Oct 20
Prospectus for primary offering
4:16pm
8-K
EX-10.1
yp0zch70kfpp
25 Sep 20
Diffusion Pharmaceuticals Strengthens Management Team with Appointmentof William Elder as General Counsel and Corporate Secretary
4:57pm